Evaluation of transjugular intrahepatic portosystemic shunt and modified sclerotherapy in preventing rebleeding of esophageal and gastric varices

• Published in: Medical engineering & physics 2022-12, Vol.110, p.103905-103905, Article 103905
• Main Authors: Wang, Daliang, Xie, Taoli, Ji, Xiaowen, Yan, Shanjun
• Format: Article
• Language: English
• Subjects: EGVB; Esophageal and gastric varices; Esophageal and Gastric Varices - complications; Esophageal and Gastric Varices - surgery; Gastrointestinal Hemorrhage - etiology; Gastrointestinal Hemorrhage - therapy; GEV; Humans; Liver Cirrhosis - complications; MES; Portasystemic Shunt, Transjugular Intrahepatic - adverse effects; Portasystemic Shunt, Transjugular Intrahepatic - methods; Recurrence; Retrospective Studies; Sclerotherapy - adverse effects; TIPS; Treatment Outcome
• ISSN: 1350-4533; 1873-4030
• DOI: 10.1016/j.medengphy.2022.103905

•The rebleeding rate after MES was higher than that of TIPS.•The incidence of hepatic encephalopathy after MES is lower than that of TIPS.•There was no significant difference in hospital stay between the two groups.•The treatment cost of the MES group was lower than that of the TIPS group.•MES is more suitable for development and promotion in primary hospitals. Esophageal and gastric varices are complications of decompensated portal hypertension due to cirrhosis, and gastrointestinal bleeding and can seriously trigger major bleeding and crisis life. Seriously endangers patients' physical and mental health and attracts great attention in the clinic. To compare the efficacy and safety of MES (combined with lauromacrogol and tissue adhesive) and TIPS in the treatment of esophageal and gastric varices. The 62 cases of esophageal and gastric variceal bleeding in our hospital were retrospectively analyzed. They were divided into the MES group and TIPS group according to the treatment method. The rebleeding rate, complications, 2-year birth rate, treatment cost, and hospitalization time within 2 years after operation were compared between the two groups. Among the 62 patients, there were 32 in the MES group and 30 in the TIPS group. The rebleeding rate within 1 year after operation in the MES group was higher than that in the TIPS group, but the difference was not statistically significant. The rebleeding rate within 2 years after operation in the MES group was 40.63%, significantly higher than 13.33% in the TIPS group (P  0.05). The treatment cost of the MES group was lower than that of the TIPS group (P